Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Alyx C. Rosen"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of the American Academy of Dermatology. 78(6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1e47a962c978d1300c68f2d257c24ec
https://pubmed.ncbi.nlm.nih.gov/29031658
https://pubmed.ncbi.nlm.nih.gov/29031658
Autor:
Alyx C. Rosen, Emily C. Case, Felipe Bochnia Cerci, Mario E. Lacouture, Shenhong Wu, Marigdalia K. Ramirez-Fort
Publikováno v:
American Journal of Clinical Oncology. 37:266-271
Everolimus is a mammalian target of rapamycin (mTOR) inhibitor approved for treatment of renal cell carcinoma, subependymal giant cell astrocytoma, breast cancer, and progressive neuroendocrine tumors of pancreatic origin. Its use may be hindered bec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::190666f84471d88a5f3f862b5dd55a3c
https://doi.org/10.1097/coc.0b013e318277d62f
https://doi.org/10.1097/coc.0b013e318277d62f
Publikováno v:
Dermatologic Therapy. 26:135-148
In the past decade, the expanded use of targeted anticancer drugs has significantly prolonged survival in patients treated for a variety of cancers. Despite their increased specificity, agents such as epidermal growth factor receptor inhibitors (EGFR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::25a84ecd691387017cb90cac1cf94a39
https://doi.org/10.1111/dth.12027
https://doi.org/10.1111/dth.12027
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 97:1125-1133
Vandetanib is an oral inhibitor of vascular endothelial growth factor receptor, epidermal growth factor receptor, and rearranged during transfection tyrosine kinases. It is approved for the treatment of unresectable or metastatic medullary thyroid ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aacae1618b391b4154ea52690d3ac9bd
https://doi.org/10.1210/jc.2011-2677
https://doi.org/10.1210/jc.2011-2677
Autor:
Diane Reidy-Lagunes, Patricia L. Myskowski, Mario E. Lacouture, Jason A. Konner, Melissa Pulitzer, Yevgeniy Balagula, Darren R. Feldman, Klaus J. Busam, Robert J. Motzer, Alyx C. Rosen, Belinda H. Tan
Publikováno v:
Cancer. 118:5078-5083
BACKGROUND: Dermatologic adverse events stemming from anticancer therapies have become an increasingly frequent clinical problem. Inhibitors of mammalian target of rapamycin (mTOR), such as temsirolimus and everolimus, have been associated with a hig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6a59ea5447c83b88353f1406a72388ed
https://doi.org/10.1002/cncr.27505
https://doi.org/10.1002/cncr.27505
Autor:
Evangelos V. Badiavas, Robert S. Kirsner, Wellington Guzman, Wasif N. Khan, Tim Ioannides, Anna J. Nichols, Emily S. Clark, Alyx C. Rosen, Adrianna Gonzalez, Harold S. Rabinovitz
Publikováno v:
JAMA Dermatology. 154:927
Importance Squamous cell carcinoma (SCC) is the second most common form of skin cancer, and its incidence is increasing. When surgical management is not an option, finding a safe and efficacious treatment is a challenge. Mounting evidence suggests th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a961f970016f1897b0e42ed3a46d3136
https://doi.org/10.1001/jamadermatol.2018.1748
https://doi.org/10.1001/jamadermatol.2018.1748
Autor:
Viswanath Reddy, Belum, Alyx C, Rosen, Natalia, Jaimes, George, Dranitsaris, Melissa P, Pulitzer, Klaus J, Busam, Ashfaq A, Marghoob, Richard D, Carvajal, Paul B, Chapman, Mario E, Lacouture
Publikováno v:
Cancer. 121(1)
The use of BRAF inhibitors may lead to the development of cutaneous toxicities such as rashes, photosensitivity, alopecia, palmoplantar erythrodysesthesia, and proliferative skin lesions, including keratoacanthomas (KAs) and cutaneous squamous cell c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ee1c9dce2649d69d0a309ea641a9a4b8
https://pubmed.ncbi.nlm.nih.gov/25186461
https://pubmed.ncbi.nlm.nih.gov/25186461
Publikováno v:
Dermatologic Principles and Practice in Oncology: Conditions of the Skin, Hair, and Nails in Cancer Patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::44cc26b2b3bde9bf545bd38e57390e99
https://doi.org/10.1002/9781118590638.ch33
https://doi.org/10.1002/9781118590638.ch33
Autor:
Jennifer Sorrell, Yevgeniy Balagula, Dennis W. Raisch, Nicole E. Larsen, Beatrice Nardone, Milan J. Anadkat, Alyx C. Rosen, Dennis P. West, Vishvas Garg, Mario E. Lacouture
Publikováno v:
Anti-cancer drugs. 25(2)
The incidences of life-threatening toxicities such as Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are inconsistently reported. The potential association of anticancer agents with SJS or TEN has not been systematically investig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a5bbb9550a53b9601f7219deb063628
https://pubmed.ncbi.nlm.nih.gov/24108082
https://pubmed.ncbi.nlm.nih.gov/24108082